ABSTRACT Objective: To demonstrate the mechanism of action mediating the acute and chronic *Department of Pharmacology, Dr.
Introduction
Africa and Madagascar but have been introduced in other tropical countries, the Mediterranean area and the West Inflammation is generally considered as an essentially Indies. [3] Aloe has been used as a folk medicine for 3000 years protective response to tissue injury caused by noxious and in the last decade Aloe vera is being extensively used in physical, chemical or microbiological stimulus. It is a complex health drinks, topical creams, toiletries and cosmetics. [4] From process involving various mediators, such as prostaglandins, leukotrienes and platelet activating factor. [1] The major the leaves of Aloe plants, three types of commercial products are obtained namely, the dried exudate, excreted from the macrophage derived inflammatory mediators such as pro inflammatory cytokines, tumour necrosis factor-α (TNF-α) aloin cells present in the zone of the vascular bundle, the and the reactive free radical nitric oxide (NO) synthesized by gel, a mucilaginous juice present in the centre of the leaf and the oil, extracted by organic solvents. [3] The dried exudate is inducible NO synthase (iNOS), contribute to the development of inflammatory diseases. [2] Thus, inhibition of the excessive used as a bitter in alcoholic beverages while the oil, production of TNF-α and/or NO could be employed as criteria comprising the fatty fraction of the leaf is used primarily in to evaluate potential antiinflammatory compounds. The the cosmetic industry as a pigment carrier and soothing current management of inflammatory diseases is limited to agent. Studies have shown that the gel component has the use of antiinflammator y drugs whose chronic antiinflammatory activity [5] that is mediated through administration is associated with several adverse effects. antibradykinin [6] activity and inhibition of prostaglandin Plant-derived products are slowly emerging as a viable production. [7] However, no studies have been undertaken with alternative because they are cheap, abundantly available and regard to the antiinflammatory activity of the leaf exudate. relatively less toxic.
Accordingly, in this study, we have evaluated the The genus Aloe belongs to the Asphodelaceae family, antiinflammatory potential of Aloe vera leaf exudate as also Alooideae subfamily, and comprises about 420 species of demonstrated that this antiinflammatory activity is mediated succulent plants. They are indigenous to southern and eastern partly via reduction of nitric oxide production in macrophages.
Materials and Methods

Animals
Male albino Wistar rats (100-120 g) and Swiss albino mice (av. wt. 25-30 g) were used. All animals were housed under standard conditions of temperature (25±5°C). A 12-h light/ dark cycle was maintained and the animals were provided with standard pellet diet and water ad libitum. They were acclimatized for one week and then subdivided for different experimental schedules. The experiments were carried out after getting approval from the Institutional Animal Ethics Committee.
Chemicals 
Tests for acute inflammation
Carrageenan or dextran-induced edema Animals were divided into four groups (n = 6). In all the groups, acute inflammation was induced by injection of either 0.1 ml of freshly prepared carrageenan (1.0 %) in 0.9 % w/v NaCl solution [8] or 0.1 ml of dextran (2%) in 0.9% w/v NaCl solution [9] into the subplantar region of the hind paw of rats. AVL in different doses (0-25 mg/kg, b.w.) and indomethacin (2.5, 5 and 10 mg/kg, b.w., as a standard reference) were orally administered one hour before injection of the phlogistic agent. The paw volumes were measured plethysmographically (using water) once prior to administration of the phlogistic agent and thereafter at hourly intervals for 3 h. The percentage of inhibition was calculated as follows [10] E -E c t X 100 E c where E c is the edema volume of the control group and E t is the edema volume of the treated group.
Test of chronic inflammation
Freund's complete adjuvant induced arthritic model Rats were divided into three groups (n = 6). Experimental arthritis was induced according to the method of Newbould et al. [11] Briefly, 0.1 ml of Freund's complete adjuvant was injected intradermally into the plantar aspect of the hind paw of each animal. Animals were administered AVL (25 mg/kg, b.w., orally) and dexamethasone (0.1 mg/kg, b.w., orally, as a standard reference) for the initial 13 days. The degree of inflammation was measured plethysmographically; accordingly, edema formation and the percentage of inhibition was calculated as described above on days 1, 3, 5, 9, 13 and 21 and the primary and the secondary lesions were measured.
Primary lesions refer to the edema formation in the injected hind paw that peaks 3-5 days after injection of the phlogistic agent and is measured on day 5 by calculating the percent inhibition of the edema volume of the injected paw using the formula described above. Secondary lesions are immunologically mediated changes characterized by inflammation of the non-injected sites (hindleg, forepaw, ears nose and tail) decrease in weight and occur after a delay of 11-12 days. Accordingly, secondary lesions were evaluated by calculating the percent inhibition of paw volume of the non injected right paw over control on day 21 and using an arthritic index as the sum of scores according to the method of Schorlemmer. [12] Lesion site Nature of lesion Score 
Preparation of mouse peritoneal macrophages
To elicit activated peritoneal macrophages, mice were injected i.p. with starch [2% in phosphate buffered saline (PBS), 0.02 M, pH 7.2, 2 ml/mice]. After three days, the peritoneal cells comprising principally macrophages were lavaged with sterile PBS (10 ml). The exudate was centrifuged at 4000 rpm for 10 min and the resultant cell pellet washed in PBS and finally resuspended in complete RPMI-1640 phenol red free medium supplemented with 10% fetal calf serum (FCS)
. [13] Macrophage viability (>95%) was confirmed by the Trypan blue dye exclusion technique.
Measurement of nitric oxide (NO) production in macrophages
Macrophages obtained by peritoneal lavage as described above were seeded (5 x 10 6 /ml) in RPMI 1640 phenol red free medium supplemented with 10% FCS in Petri dishes (35 mm diameter) and incubated at 37°C, 5% CO 2 for 4 hrs. AVL (0 10.0 µg/ml) was added and incubated for an additional 48 hrs. At the end of 48 h, 0.5 ml of the supernatant was withdrawn and nitrite accumulation as an indicator of NO production was measured using Griess reagent. [14] Briefly, 0.5 ml of Griess reagent [mixture of 1:1 of napthylethylenediamine dihydrochloride (0.1% in water) and sulphanilamide (1% in 5% phosphoric acid)] was added to 0.5 ml of supernatant and incubated in the dark at room temperature (25-30°C) for 10 min. Finally, absorbance at 546 nm was measured spectrophotometrically and a standard curve using sodium nitrite was used to calculate concentrations of nitrite. To demonstrate specificity, macrophages were incubated in the presence of N-monomethyl arginine [(L-NMMA), 0.1mM] an established inhibitor of NO production.
Cytotoxicity assay
To determine the viability of macrophages in the presence of AVL or DMSO, they were seeded in 96-well tissue culture plates (1 x 10 6 cells/ml of RPMI 1640, supplemented with 10% FCS, 0.2 ml per well) and incubated with either AVL (0 -10 mg/ml) or DMSO (0-1%) alone for 48 hrs. At the end of drug exposure, the MTS assay was performed. [15] Briefly, MTS [{3 (4, 5 dimethylthiazol-2-yl)-5-(carboxymethoxy-phenyl}-2-(4 sulphophenyl)-2H tetrazolium] was prepared (2 mg/ml in PBS) and stored in dark at -20°C. Another stock solution of phenazine methosulphate (PMS) was prepared (0.92 mg/ml in PBS) and stored -20°C. Just before use, MTS and PMS were mixed in the ratio of 20:1 and 20 µl of the solution was added to each well. The plates were then incubated at 37°C for 3 hrs and absorbances measured at 490 nm using a Multiskan ELISA reader (BioRad, USA).
Statistical analysis Data were expressed as mean±SEM and statistically assessed using one-way ANOVA followed by Tukey test; P<0.05 was considered significant. Results AVL possesses strong acute antiinflammatory activity in carrageenan and dextran-induced animal models of inflammation AVL at 25 mg/kg, b.w., showed significant antiinflammatory activity in both carrageenan and dextran models. In the control group, paw volume was maximum at the third hour after which the paw volume decreased gradually and therefore readings up to the third hour were recorded (Tables 1 and 2 ). However, the antiinflammatory activity of AVL was sustained up to the sixth hour (data not shown). Indomethacin served as a positive control and was initially tested at three different concentrations of 2.5, 5.0 and 10.0 mg/kg, b.w. With 2.5 and 5.0 mg/kg, b.w., a maximum of 19.53% and 21.65% reduction in paw edema, respectively, was obtained. However, with 10 mg/kg, b.w., a marked reduction of 75% was obtained and accordingly, this concentration was selected for all experiments.
Chronic antiinflammatory activity of AVL in a complete Freund's adjuvant-induced model of arthritis.
A significant decrease in the primary lesion as evident on day 5 was observed with both AVL (33.3%, P<0.05) and the dexamethasone treated group (57.69%, P<0.007) [ Table 3 , Figure 1 ] as compared to controls. With regard to the secondary lesions, it could only be partially evaluated as no edema formation was evident in the contralateral hind paw of control animals. On the 21st day, a significant decrease in edema volume was observed in the injected paw of both AVL (52.7%, P<0.01) and dexamethasone-treated group (63.51%, P<0.005).
With regard to the mean arthritic index, the score of AVL treated animals was not different from that of the control group being 2.0 vs. 1.8, respectively, indicating that AVL does not possess antiarthritic activity. As expected, the dexamethasone treated group showed profound antiarthritic activity since it decreased the arthritic index almost 10-fold being 0.17.
AVL-treated macrophages showed decreased nitric oxide (NO) production
The formation of NO is classically assayed by measuring nitrite (NO 2 -) production, a primary, stable and nonvolatile breakdown product of NO. The Griess reagent uses sulphanilamide and NED under acidic conditions to yield an azo compound that can be measured spectrophotometrically. AVL caused a 43.64% decrease in NO production in murine macrophages as compared to control values being 31.0 µM vs. 55.0 µM. The marked decrease in NO production in the presence of L-NMMA (8.75 µM) confirmed specificity of the reaction.
Toxicity of AVL in macrophages As AVL decreased NO production in macrophages, it was relevant to confirm that this decrease was not due to AVL or DMSO induced cell death but specifically by macrophage * Sarkar et al. 
DMSO (% )
Arthritis was established using complete Freund's adjuvant and the animals received no drug (-� -), AVL (-� -, 25 mg/kg b.w.) or dexamethasone (-�-, 0.1 mg/kg b.w.). The degree of inhibition of edema formation was measured plethysmographically on days 3, 5, 9, 13 and 21. Each point is the mean ± SEM of two experiments (n=6 in each group), *P<0.05; **P<0.01;***P<0.005 as compared to control (one-way ANOVA followed by Tukey test).
inactivation. Accordingly, macrophages were incubated with A: Macrophages were incubated with DMSO (0 -1%) in 96 well plates at 37 o C and 5% CO 2 for 48 h. Each point is the mean ± SEM of three experiments in duplicates, *P<0.0001 as compared to control (one way ANOVA followed by Tukey test).
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AVL or DMSO and cell viability was determined by the MTS assay. Since this conversion can only be accomplished by viable cells, the amount of formazan is a direct measure of the number of cells present. [14] It was found that DMSO up to 0.5% was nontoxic to macrophages (Figure 2A , p= 0.72). However, with 1.0% DMSO, a significant increase in toxicity was observed Accordingly, all experiments were performed using a maximum of 0.1% DMSO or 0.1 mg/ml AVL.
Discussion
The inhibition of carrageenan-induced inflammation in rats is an established model to screen compounds for potential antiinflammatory activity. According to Vinegar et al. (1987) , [16] the development of carrageenan-induced edema is biphasic; the first phase occurs within one hour of carrageenan administration and is attributed to the release of cytoplasmic enzymes, histamine and serotonin, from the mast cells. The second phase (>1.0 h) is mediated by an increased release of prostaglandins in the inflammatory area and continuity between the two phases is provided by kinins. With regard to dextran-induced edema, it has been reported to be mediated mainly by histamine and 5-HT released by the mast cells. [17] Taken together, it suggests that as AVL possesses potent acute antiinflammatory activity (Tables 1 and 2) , it is mediated possibly due to inhibition of the synthesis and/or release of mediators of inflammation, principally the prostaglandins. This can only be defined after developing models of inflammation using specific mediators.
The immunologically mediated complete Freund's adjuvant arthritic model of chronic inflammation is considered as the best available experimental model of rheumatoid arthritis. [18] This method in rats was originally developed by Pearson et al. (1963) , [19] wherein an injection of complete Freund's adjuvant in the rat hind paw induces inflammation. It has been proposed that bacterial peptido glycan and muramyl dipeptide are important nonspecific immunogenic contributory components. In this model of immunologically mediated chronic synovial inflammation and arthritis, macrophages play a central role. After activation they are capable of synthesizing mediators such as PGE 2 and cytokines such as TNF-α and IL-1. In turn, these synthetic products induce the production of a variety of enzymes which initiate cartilage and bone destruction. [20] , [21] NO is an important physiological messenger and effector molecule in many biological systems, including immunological, neuronal and cardiovascular tissues. [22] Nitric oxide, in macrophages, is produced as a free radical by iNOS by catalyzing the oxidation of guanidino nitrogen of L-arginine, thereby converting L-arginine to L-citrulline. [22] NO is an important signalling and effector molecule in inflammation and immunity as it is known to couple with superoxides to form peroxynitrite. These, in turn, induce the production of prostaglandin endoperoxide synthase from monocytes/ macrophages resulting in enhanced synthesis of prostaglandins, established mediators of inflammation.
[23] The reduced NO production by macrophages in the presence of AVL suggests that AVL by decreasing the release of NO, inhibits the release of inflammatory inhibitors such as prostaglandins resulting in suppression of inflammation. This can be confirmed by measuring the expression of iNOS in macrophages; such studies are ongoing.
